|
1
|
Sullivan R: Cancer research in the UK: A
policy review of the junior academic clinical faculty. Mol Oncol.
1:366–373. 2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rooth C: Ovarian cancer: Risk factors,
treatment and management. Br J Nurs. 22 (Suppl 17):S23–S30.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lin X, Feng D, Li P and Lv Y: LncRNA
LINC00857 regulates the progression and glycolysis in ovarian
cancer by modulating the Hippo signaling pathway. Cancer Med.
9:8122–8132. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jelovac D and Armstrong DK: Recent
progress in the diagnosis and treatment of ovarian cancer. CA
Cancer J Clin. 61:183–203. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lou Y, Jiang H, Cui Z, Wang X, Wang L and
Han Y: Gene microarray analysis of lncRNA and mRNA expression
profiles in patients with highgrade ovarian serous cancer. Int J
Mol Med. 42:91–104. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang M, Song Y and Yu L: LncRNA PTCSC3
suppressed cervical carcinoma cell invasion and proliferation via
regulating miR-574-5p. Am J Transl Res. 11:7186–7194.
2019.PubMed/NCBI
|
|
8
|
Yuan L, Ma T, Liu W, Chen Y, Yuan Q, Ye M,
Yu L, Li J, Niu Y and Nan Y: LINC00994 promoted invasion and
proliferation of gastric cancer cell via regulating miR-765-3p. Am
J Transl Res. 11:6641–6649. 2019.PubMed/NCBI
|
|
9
|
Yin X, Zhang J, Li C, Zhang Z, Jin T, Song
L, Zhang R, Wang W, Tao Y and Wang X: LncRNA HOXA11-AS
accumulation-induced microRNA-761 downregulation regulates cell
growth by targeting TRIM29 in papillary thyroid cancer. Am J Transl
Res. 11:6826–6837. 2019.PubMed/NCBI
|
|
10
|
Lei X, Yang S, Yang Y, Zhang J, Wang Y and
Cao M: Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to
accelerate Ewing's sarcoma. Am J Transl Res. 11:6569–6576.
2019.PubMed/NCBI
|
|
11
|
Wang WL, Yu DJ and Zhong M: LncRNA HAGLROS
accelerates the progression of lung carcinoma via sponging
microRNA-152. Eur Rev Med Pharmacol Sci. 23:6531–6538.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wei H, Hu J, Pu J, Tang Q, Li W, Ma R, Xu
Z, Tan C, Yao T, Wu X, et al: Long noncoding RNA HAGLROS promotes
cell proliferation, inhibits apoptosis and enhances autophagy via
regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells.
Int Immunopharmacol. 73:72–80. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yang M, Zhai Z, Zhang Y and Wang Y:
Clinical significance and oncogene function of long noncoding RNA
HAGLROS overexpression in ovarian cancer. Arch Gynecol Obstet.
300:703–710. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Han G, Qiu N, Luo K, Liang H and Li H:
Downregulation of miroRNA-141 mediates acquired resistance to
trastuzumab and is associated with poor outcome in breast cancer by
upregulating the expression of ERBB4. J Cell Biochem: Feb 11, 2019
(Epub ahead of print).
|
|
15
|
Yu FQ, Wang Z, Wang XW, Wang SL, Li XD,
Huang QS and Lin JH: MicroRNA-885-5p promotes osteosarcoma
proliferation and migration by downregulation of cell division
cycle protein 73 homolog expression. Oncol Lett. 17:1565–1572.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dejene SB, Ohman AW, Du W, Randhawa D,
Bradley A, Yadav N, Elias KM, Dinulescu DM and Setlur SR: Defining
fallopian tube-derived miRNA cancer signatures. Cancer Med.
8:6709–6716. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhou A, Pan H, Sun D, Xu H, Zhang C, Chen
X, Li L and Wang T: miR-26b-5p inhibits the proliferation,
migration and invasion of human papillary thyroid cancer in a
β-catenin-dependent manner. Onco Targets Ther. 13:1593–1603.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jia CM, Tian YY, Quan LN, Jiang L and Liu
AC: miR-26b-5p suppresses proliferation and promotes apoptosis in
multiple myeloma cells by targeting JAG1. Pathol Res Pract.
214:1388–1394. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Paraskevopoulou MD, Vlachos IS, Karagkouni
D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P,
Floros E, Dalamagas T and Hatzigeorgiou AG: DIANA-LncBase v2:
Indexing microRNA targets on non-coding transcripts. Nucleic Acids
Res. 44:D231–D238. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xu HY, Wang LY and Jiang XL: Silencing of
lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via
regulating miR-429/TFAP2A axis. Mol Cell Biochem. 476:1051–1061.
2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Du LJ, Mao LJ and Jing RJ: Long noncoding
RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small
cell lung cancer via regulating miR-877-5p/CCNA2 pathway. Biochem
Biophys Res Commun. 533:565–572. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang XJ, Qi GT, Zhang XM, Wang L and Li
FF: lncRNA RHPN1-AS1 promotes the progression of endometrial cancer
through the activation of ERK/MAPK pathway. J Obstet Gynaecol Res.
47:533–543. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yao HP, Chen R, Yang YX and Jiang J:
LncRNA BBOX1-AS1 aggravates the development of ovarian cancer by
sequestering miR-361-3p to augment PODXL expression. Reprod Sci.
28:736–744. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liu MH, Han T, Shi SM and Chen EQ: Long
noncoding RNA HAGLROS regulates cell apoptosis and autophagy in
lipopolysaccharides-induced WI-38 cells via modulating miR-100/
NF-kappa B axis. Biochem Biophys Res Commun. 500:589–596.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhou KF, Xu J, Yin XF and Xia JN: Long
noncoding RNA HAGLROS promotes cell invasion and metastasis by
sponging miR-152 and upregulating ROCK1 expression in osteosarcoma.
Comput Math Method Med. 2020(7236245)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen JF, Wu P, Xia R, Yang J, Huo XY, Gu
DY, Tang CJ, De W and Yang F: STAT3-induced lncRNA HAGLROS
overexpression contributes to the malignant progression of gastric
cancer cells via mTOR signal-mediated inhibition of autophagy. Mol
Cancer. 17(6)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chen Y, Shen T, Ding X, Cheng L, Sheng L
and Du X: HAGLROS is overexpressed and promotes non-small cell lung
cancer migration and invasion. Jpn J Clin Oncol. 50:1058–1067.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer.
13(92)2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen P, Zhao X, Wang H, Zheng M, Wang Q
and Chang W: The down-regulation of lncRNA PCAT18 promotes the
progression of gastric cancer via MiR-107/PTEN/PI3K/AKT signaling
pathway. Onco Targets Ther. 12:11017–11031. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wu K, Mu XY, Jiang JT, Tan MY, Wang RJ,
Zhou WJ, Wang X, He YY, Li MQ and Liu ZH: miRNA26a5p and miR26b5p
inhibit the proliferation of bladder cancer cells by regulating
PDCD10. Oncol Rep. 40:3523–3532. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lu J, Zhang W, Ding Y, Li X and Song J:
Expression of miR-26b in ovarian carcinoma tissues and its
correlation with clinicopathology. Oncol Lett. 17:4417–4422.
2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li D, Wei Y, Wang D, Gao H and Liu K:
MicroRNA-26b suppresses the metastasis of non-small cell lung
cancer by targeting MIEN1 via NF-kappaB/MMP-9/VEGF pathways.
Biochem Biophys Res Commun. 472:465–470. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu J, Tu F, Yao W, Li X, Xie Z, Liu H, Li
Q and Pan Z: Conserved miR-26b enhances ovarian granulosa cell
apoptosis through HAS2-HA-CD44-Caspase-3 pathway by targeting HAS2.
Sci Rep. 6(21197)2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kato M, Goto Y, Matsushita R, Kurozumi A,
Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M,
Ichikawa T and Seki N: MicroRNA-26a/b directly regulate La-related
protein 1 and inhibit cancer cell invasion in prostate cancer. Int
J Oncol. 47:710–718. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Fukumoto I, Kikkawa N, Matsushita R, Kato
M, Kurozumi A, Nishikawa R, Goto Y, Koshizuka K, Hanazawa T,
Enokida H, et al: Tumor-suppressive microRNAs (miR-26a/b,
miR-29a/b/c and miR-218) concertedly suppressed
metastasis-promoting LOXL2 in head and neck squamous cell
carcinoma. J Hum Genet. 61:109–118. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu SN, Li L, Li MH and Zhang JJ: Effect
of miR-26b-5p on cis-diamine dichloroplatinum-induced ovarian
granulosa cell injury by targeting MAP3K9. In Vitro Cell Dev Biol
Anim. 56:213–221. 2020.PubMed/NCBI View Article : Google Scholar
|
